Additionally, several cell cycle-related genes have recently been identified as potential therapeutic targets for the treatment of HCC, including CDK1 [49], CDK4 [47], CCNB1 [50], and CHEK1 [51]. The gene discussed is CDK4; the disease is hepatocellular carcinoma.